Skip to main content

and
  1. No Access

    Article

    Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

    Epigenetic therapies demonstrate significant clinical activity in acute myeloid leukemia (AML) and myelodysplasia (MDS) and constitute an important new class of therapeutic agents. However hematological respon...

    C Craddock, L Quek, N Goardon, S Freeman, S Siddique, M Raghavan, A Aztberger in Leukemia (2013)